Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anish Mehta

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of Drug Assessment|October 28, 2016
Montelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trialKimihiro Okubo, Yoichi Inoue, Hirotaka Numaguchi, et al.
The Journal of Allergy and Clinical Immunology|February 6, 2013
Effect of montelukast for treatment of asthma in cigarette smokersDavid Price, Todor A Popov, Leif Bjermer, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|October 22, 2013
Odanacatib does not influence the single dose pharmacokinetics and pharmacodynamics of warfarinS Aubrey Stoch, Rose Witter, David Hrenuik, et al.
BMC Musculoskeletal Disorders|October 26, 2013
Evaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trialNarinder Rawal, Eugene Viscusi, Paul M Peloso, et al.
The Clinical Journal of Pain|December 19, 2012
Evaluation of multiday analgesia with etoricoxib in a double-blind, randomized controlled trial using the postoperative third-molar extraction dental pain modelJean D Brown, Stephen E Daniels, Donald P Bandy, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2013
Odanacatib, a selective cathepsin K inhibitor, demonstrates comparable pharmacodynamics and pharmacokinetics in older men and postmenopausal womenMatt S Anderson, Isaias Noel Gendrano, Chengcheng Liu, et al.
Journal of Clinical Pharmacology|June 21, 2016
Coadministration of Rifampin Significantly Reduces Odanacatib Concentrations in Healthy SubjectsS Aubrey Stoch, Jeanine Ballard, Christopher Gibson, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 21, 2013
Absence of clinically relevant drug-drug interaction between odanacatib and digoxin after concomitant administrationS Aubrey Stoch, Rose Witter, David Hreniuk, et al.
Current Medical Research and Opinion|June 25, 2014
Etoricoxib in the treatment of primary dysmenorrhea in Chinese patients: a randomized controlled trialQi Yu, Xiaqin Zhu, Xiaowei Zhang, et al.
Current Medical Research and Opinion|June 29, 2012
Perioperative use of etoricoxib reduces pain and opioid side-effects after total abdominal hysterectomy: a double-blind, randomized, placebo-controlled phase III studyEugene R Viscusi, Tara L Frenkl, Craig T Hartrick, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of Drug Assessment|October 28, 2016
Montelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trialKimihiro Okubo, Yoichi Inoue, Hirotaka Numaguchi, et al.
The Journal of Allergy and Clinical Immunology|February 6, 2013
Effect of montelukast for treatment of asthma in cigarette smokersDavid Price, Todor A Popov, Leif Bjermer, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|October 22, 2013
Odanacatib does not influence the single dose pharmacokinetics and pharmacodynamics of warfarinS Aubrey Stoch, Rose Witter, David Hrenuik, et al.
BMC Musculoskeletal Disorders|October 26, 2013
Evaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trialNarinder Rawal, Eugene Viscusi, Paul M Peloso, et al.
The Clinical Journal of Pain|December 19, 2012
Evaluation of multiday analgesia with etoricoxib in a double-blind, randomized controlled trial using the postoperative third-molar extraction dental pain modelJean D Brown, Stephen E Daniels, Donald P Bandy, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2013
Odanacatib, a selective cathepsin K inhibitor, demonstrates comparable pharmacodynamics and pharmacokinetics in older men and postmenopausal womenMatt S Anderson, Isaias Noel Gendrano, Chengcheng Liu, et al.
Journal of Clinical Pharmacology|June 21, 2016
Coadministration of Rifampin Significantly Reduces Odanacatib Concentrations in Healthy SubjectsS Aubrey Stoch, Jeanine Ballard, Christopher Gibson, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 21, 2013
Absence of clinically relevant drug-drug interaction between odanacatib and digoxin after concomitant administrationS Aubrey Stoch, Rose Witter, David Hreniuk, et al.
Current Medical Research and Opinion|June 25, 2014
Etoricoxib in the treatment of primary dysmenorrhea in Chinese patients: a randomized controlled trialQi Yu, Xiaqin Zhu, Xiaowei Zhang, et al.
Current Medical Research and Opinion|June 29, 2012
Perioperative use of etoricoxib reduces pain and opioid side-effects after total abdominal hysterectomy: a double-blind, randomized, placebo-controlled phase III studyEugene R Viscusi, Tara L Frenkl, Craig T Hartrick, et al.
Pageof 8